Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 19179235)

1.

ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.

Rosenzweig KE, Movsas B, Bradley J, Gewanter RM, Gopal RS, Komaki RU, Kong FM, Lee HK, Feins RH, Langer CJ.

J Am Coll Radiol. 2009 Feb;6(2):85-95. doi: 10.1016/j.jacr.2008.11.001.

PMID:
19179235
2.

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.

Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, et al.

J Natl Cancer Inst. 1995 Feb 1;87(3):198-205.

PMID:
7707407
3.
4.

[Treatment outcome of locally advanced stage IIIA/B lung cancer].

Cicenas S, Zaliene A, Atkocius V.

Medicina (Kaunas). 2009;45(6):452-9. Lithuanian.

5.

Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial.

Pöttgen C, Eberhardt W, Bildat S, Stüben G, Stamatis G, Hillejan L, Sohrab S, Teschler H, Seeber S, Sack H, Stuschke M.

Ann Oncol. 2002 Mar;13(3):403-11.

6.

Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.

Komaki R, Scott C, Lee JS, Urtasun RC, Byhardt RW, Emami B, Andras EJ, Asbell SO, Rotman M, Cox JD.

Am J Clin Oncol. 1997 Oct;20(5):435-40.

PMID:
9345325
7.

Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.

Zwitter M, Kovac V, Smrdel U, Strojan P.

J Thorac Oncol. 2006 Sep;1(7):662-6.

PMID:
17409933
8.

Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.

Lee SW, Choi EK, Lee JS, Lee SD, Suh C, Kim SW, Kim WS, Ahn SD, Yi BY, Kim JH, Noh YJ, Kim SS, Koh Y, Kim DS, Kim WD.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):996-1004.

PMID:
12829135
9.

Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?

Numico G, Russi E, Merlano M.

Lung Cancer. 2001 Jun;32(3):213-26. Review.

PMID:
11390003
10.

Gefitinib therapy for non-small cell lung cancer.

Birnbaum A, Ready N.

Curr Treat Options Oncol. 2005 Jan;6(1):75-81. Review.

PMID:
15610717
11.

High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.

Rosenman JG, Halle JS, Socinski MA, Deschesne K, Moore DT, Johnson H, Fraser R, Morris DE.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):348-56.

PMID:
12243807
13.

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR.

J Natl Cancer Inst. 1996 Sep 4;88(17):1210-5.

14.
16.
17.

A systematic overview of chemotherapy effects in non-small cell lung cancer.

Sörenson S, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):327-39. Review.

PMID:
11441939
18.

[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma].

Bardet E, Moro-Sibilot D, Le Chevalier T, Massard G, Douillard JY, Theobald S, Astoul P, Baldeyrou P, Bazelly B, Bréchot J, Breton JL, Grivaux P, Jacoulet P, Khalil A, Lemarie E, Martinet Y, Milleron B, Paesmans M, Pujol JL, Quoix AE, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stcebner-Delbarre A, Thiberville L, Touboul E, Vaylet F, Vergnon JM, Westeel V, Depierre A, Lagrange JL.

Bull Cancer. 2001 Apr;88(4):369-87. Review. French.

PMID:
11371371
19.

Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.

Mirimanoff RO, Moro D, Bolla M, Michel G, Brambilla C, Mermillod B, Miralbell R, Alberto P.

Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):487-94.

PMID:
9806505
20.

Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.

Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, Mehta M; Eastern Cooperative Oncology Group.

J Clin Oncol. 2005 Jun 1;23(16):3760-7. Epub 2005 Apr 18. Review.

PMID:
15837967
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk